Erratum

Withdrawal: BRCA1-induced apoptosis involves inactivation of ERK1/2 activities (Journal of Biological Chemistry (2002) 277 (33422–33430) DOI: 10.1074/jbc.M201147200)

Ying Yan, John P Haas, Min Kim, Magdalene K. Sgagias, Kenneth H Cowan

Research output: Contribution to journalComment/debate

Abstract

This article has been withdrawn by Ying Yan and Kenneth H. Cowan. John P. Haas, Min Kim, and Magdalene K. Sgagias could not be reached. The first author identified some issues and brought them to the attention of the Journal. Subsequently, some issues were also noted in the article by the Journal. After careful analysis of all of the original data used for preparing the figures in the publication, the following errors were identified: The Actin immunoblot in the original Fig. 1A (identified from MCF-7) was used in the immunoblot for Fig. 6C (ERK1/2, lanes 3-4). In Fig. 2B (left panel, MCF7 cells), the Actin immunoblots for Ad.Control and Ad.BRCA1 were incorrect. The authors state that the Actin immunoblot for Ad.Control and Ad.BRCA1-infected MCF7 cells in Fig. 2B should have used the same Actin immunoblot depicted in Fig. 3 for MCF-7 cells infected with Ad.Control and Ad.BRCA1 as the results shown in Fig. 2B and Fig. 3 used the same set of lysates that were also probed for PARP (Fig. 2B) and Fas-L and Fas (Fig. 3). The JNK immunoblot in Fig. 4 (MCF-7) was reused as the Actin immunoblot in Fig. 4 (right panel) and the Actin immunoblot in Fig. 5E. The authors state that the top label for Fig. 7 (left panel) was incorrect and should have used the same top label shown in Fig. 5C. Both Figs. 5C and 7 (left panel) depict results obtained from the same MCF7 cell lysates infected with Ad.Control or Ad.BRCA1 in the presence (+) or absence (-) of PD98059. The Actin immunoblots depicted in Fig. 6Cand in Fig. 7 (right Panel) were incorrect. The correct immunoblots for all of these figures listed above were found and submitted to the Journal. Given these errors, the withdrawing authors state that the responsible course of action would be to withdraw the article to maintain the high standards and rigor of scientific literature from the withdrawing authors' group as well as the Journal. However, the withdrawing authors state that these errors do not change the underlying scientific findings of the article.

Original languageEnglish (US)
Number of pages1
JournalJournal of Biological Chemistry
Volume294
Issue number20
DOIs
StatePublished - Jan 1 2019

Fingerprint

Actins
Apoptosis
MCF-7 Cells
Labels
Literature
Ficus
Publications

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

@article{50e136b6a2ff4d82b13e47f0f4f6988e,
title = "Erratum: Withdrawal: BRCA1-induced apoptosis involves inactivation of ERK1/2 activities (Journal of Biological Chemistry (2002) 277 (33422–33430) DOI: 10.1074/jbc.M201147200)",
abstract = "This article has been withdrawn by Ying Yan and Kenneth H. Cowan. John P. Haas, Min Kim, and Magdalene K. Sgagias could not be reached. The first author identified some issues and brought them to the attention of the Journal. Subsequently, some issues were also noted in the article by the Journal. After careful analysis of all of the original data used for preparing the figures in the publication, the following errors were identified: The Actin immunoblot in the original Fig. 1A (identified from MCF-7) was used in the immunoblot for Fig. 6C (ERK1/2, lanes 3-4). In Fig. 2B (left panel, MCF7 cells), the Actin immunoblots for Ad.Control and Ad.BRCA1 were incorrect. The authors state that the Actin immunoblot for Ad.Control and Ad.BRCA1-infected MCF7 cells in Fig. 2B should have used the same Actin immunoblot depicted in Fig. 3 for MCF-7 cells infected with Ad.Control and Ad.BRCA1 as the results shown in Fig. 2B and Fig. 3 used the same set of lysates that were also probed for PARP (Fig. 2B) and Fas-L and Fas (Fig. 3). The JNK immunoblot in Fig. 4 (MCF-7) was reused as the Actin immunoblot in Fig. 4 (right panel) and the Actin immunoblot in Fig. 5E. The authors state that the top label for Fig. 7 (left panel) was incorrect and should have used the same top label shown in Fig. 5C. Both Figs. 5C and 7 (left panel) depict results obtained from the same MCF7 cell lysates infected with Ad.Control or Ad.BRCA1 in the presence (+) or absence (-) of PD98059. The Actin immunoblots depicted in Fig. 6Cand in Fig. 7 (right Panel) were incorrect. The correct immunoblots for all of these figures listed above were found and submitted to the Journal. Given these errors, the withdrawing authors state that the responsible course of action would be to withdraw the article to maintain the high standards and rigor of scientific literature from the withdrawing authors' group as well as the Journal. However, the withdrawing authors state that these errors do not change the underlying scientific findings of the article.",
author = "Ying Yan and Haas, {John P} and Min Kim and Sgagias, {Magdalene K.} and Cowan, {Kenneth H}",
year = "2019",
month = "1",
day = "1",
doi = "10.1074/jbc.W119.009053",
language = "English (US)",
volume = "294",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "20",

}

TY - JOUR

T1 - Erratum

T2 - Withdrawal: BRCA1-induced apoptosis involves inactivation of ERK1/2 activities (Journal of Biological Chemistry (2002) 277 (33422–33430) DOI: 10.1074/jbc.M201147200)

AU - Yan, Ying

AU - Haas, John P

AU - Kim, Min

AU - Sgagias, Magdalene K.

AU - Cowan, Kenneth H

PY - 2019/1/1

Y1 - 2019/1/1

N2 - This article has been withdrawn by Ying Yan and Kenneth H. Cowan. John P. Haas, Min Kim, and Magdalene K. Sgagias could not be reached. The first author identified some issues and brought them to the attention of the Journal. Subsequently, some issues were also noted in the article by the Journal. After careful analysis of all of the original data used for preparing the figures in the publication, the following errors were identified: The Actin immunoblot in the original Fig. 1A (identified from MCF-7) was used in the immunoblot for Fig. 6C (ERK1/2, lanes 3-4). In Fig. 2B (left panel, MCF7 cells), the Actin immunoblots for Ad.Control and Ad.BRCA1 were incorrect. The authors state that the Actin immunoblot for Ad.Control and Ad.BRCA1-infected MCF7 cells in Fig. 2B should have used the same Actin immunoblot depicted in Fig. 3 for MCF-7 cells infected with Ad.Control and Ad.BRCA1 as the results shown in Fig. 2B and Fig. 3 used the same set of lysates that were also probed for PARP (Fig. 2B) and Fas-L and Fas (Fig. 3). The JNK immunoblot in Fig. 4 (MCF-7) was reused as the Actin immunoblot in Fig. 4 (right panel) and the Actin immunoblot in Fig. 5E. The authors state that the top label for Fig. 7 (left panel) was incorrect and should have used the same top label shown in Fig. 5C. Both Figs. 5C and 7 (left panel) depict results obtained from the same MCF7 cell lysates infected with Ad.Control or Ad.BRCA1 in the presence (+) or absence (-) of PD98059. The Actin immunoblots depicted in Fig. 6Cand in Fig. 7 (right Panel) were incorrect. The correct immunoblots for all of these figures listed above were found and submitted to the Journal. Given these errors, the withdrawing authors state that the responsible course of action would be to withdraw the article to maintain the high standards and rigor of scientific literature from the withdrawing authors' group as well as the Journal. However, the withdrawing authors state that these errors do not change the underlying scientific findings of the article.

AB - This article has been withdrawn by Ying Yan and Kenneth H. Cowan. John P. Haas, Min Kim, and Magdalene K. Sgagias could not be reached. The first author identified some issues and brought them to the attention of the Journal. Subsequently, some issues were also noted in the article by the Journal. After careful analysis of all of the original data used for preparing the figures in the publication, the following errors were identified: The Actin immunoblot in the original Fig. 1A (identified from MCF-7) was used in the immunoblot for Fig. 6C (ERK1/2, lanes 3-4). In Fig. 2B (left panel, MCF7 cells), the Actin immunoblots for Ad.Control and Ad.BRCA1 were incorrect. The authors state that the Actin immunoblot for Ad.Control and Ad.BRCA1-infected MCF7 cells in Fig. 2B should have used the same Actin immunoblot depicted in Fig. 3 for MCF-7 cells infected with Ad.Control and Ad.BRCA1 as the results shown in Fig. 2B and Fig. 3 used the same set of lysates that were also probed for PARP (Fig. 2B) and Fas-L and Fas (Fig. 3). The JNK immunoblot in Fig. 4 (MCF-7) was reused as the Actin immunoblot in Fig. 4 (right panel) and the Actin immunoblot in Fig. 5E. The authors state that the top label for Fig. 7 (left panel) was incorrect and should have used the same top label shown in Fig. 5C. Both Figs. 5C and 7 (left panel) depict results obtained from the same MCF7 cell lysates infected with Ad.Control or Ad.BRCA1 in the presence (+) or absence (-) of PD98059. The Actin immunoblots depicted in Fig. 6Cand in Fig. 7 (right Panel) were incorrect. The correct immunoblots for all of these figures listed above were found and submitted to the Journal. Given these errors, the withdrawing authors state that the responsible course of action would be to withdraw the article to maintain the high standards and rigor of scientific literature from the withdrawing authors' group as well as the Journal. However, the withdrawing authors state that these errors do not change the underlying scientific findings of the article.

UR - http://www.scopus.com/inward/record.url?scp=85066233921&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85066233921&partnerID=8YFLogxK

U2 - 10.1074/jbc.W119.009053

DO - 10.1074/jbc.W119.009053

M3 - Comment/debate

VL - 294

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 20

ER -